新型纳和胺衍生物:分子设计,系统优化,抗真菌评估和作用机制
Feng Peng1,2, Lang Tai1, Aobei Zhang1
1College of Sciences, Nanjing Agricultural University, Nanjing 210095, China.
Journal of agricultural and food chemistry
|April 30, 2025
概括
研究人员使用系统优化策略开发了新的抗真菌化合物. 化合物A32在体外和体内对Rhizoctonia solani表现出极好的疗效,提供了一个有前途的新型杀菌剂.
科学领域:
- 农业化学 农业化学
- 菌类学 菌类学是指菌类学.
- 药用化学 医学化学
背景情况:
- 开发新的抗真菌剂对于作物保护至关重要.
- 现有的杀菌剂面临着诸如耐药性和环境影响等挑战.
- 马莱胺衍生物为抗真菌发现提供了一个有前途的支架.
研究的目的:
- 设计和合成新型的甲基和甲胺衍生物.
- 评估这些衍生物的体外和体内抗真菌活性.
- 阐明最强效化合物的作用机制.
主要方法:
- 复合体设计的系统结构优化策略.
- 合成和结构确认 (X射线衍射) 的maleimide衍生物.
- 在体外和体外的抗真菌测定对Rhizoctonia solani.
- 扫描电子显微镜 (SEM) 和细胞膜透性测试.
- 分子动力学 (MD) 模拟和分子对接研究.
主要成果:
- 化合物A32在体外表现出强大的抗真菌活性 (EC50 = 0.59μg/mL) 对抗Rhizoctonia solani,表现优于二甲.
- 在体内研究表明,A32在米植物上提供了对R. solani的杰出保护效率.
- A32严重损坏了真菌菌体结构,并增加了细胞膜的透性.
- 分子对接揭示了A32与血膜H+-ATPases (PMA1) 结合,具有有利的相互作用,包括与对照组相比增强的结合.
结论:
- 系统优化策略在发现新型抗真菌化合物方面是有效的.
- 化合物A32是开发新型杀菌剂的非常有前途的头,其潜在的机制涉及PMA1抑制.
- 这项研究提供了一种实用方法,用于识别农业应用的新抗真菌剂.
相关概念视频
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


